Shattuck Labs, Inc.
STTK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680367
In the last 90 days, Shattuck Labs, Inc. insiders filed 0 open-market purchases and 3 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $581.3M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Shattuck Labs, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +17 vs. Q1 2026
- Shares held
- 83.8M
- +27.7M (+49.4%) vs. Q1 2026
- Total value
- $581.3M
- +$220.9M (+61.3%) vs. Q1 2026
- New holders
- 37
- 36 more added
- Sold out
- 20
- 15 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STTK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 100 | $581.3M |
| Q1 2026 | 84 | $360.4M |
| Q4 2025 | 65 | $153.4M |
| Q3 2025 | 56 | $87.0M |
| Q2 2025 | 61 | $22.7M |
| Q1 2025 | 75 | $29.6M |
| Q4 2024 | 75 | $38.3M |
| Q3 2024 | 78 | $124.8M |
| Q2 2024 | 74 | $131.9M |
| Q1 2024 | 70 | $281.3M |
| Q4 2023 | 57 | $207.8M |
| Q3 2023 | 41 | $30.2M |
| Q2 2023 | 42 | $62.9M |
| Q1 2023 | 49 | $59.7M |
| Q4 2022 | 48 | $46.9M |
| Q3 2022 | 63 | $55.7M |
| Q2 2022 | 72 | $87.0M |
| Q1 2022 | 77 | $102.1M |
| Q4 2021 | 82 | $204.6M |
| Q3 2021 | 70 | $525.3M |
| Q2 2021 | 68 | $750.7M |
| Q1 2021 | 56 | $682.7M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Shattuck Labs, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Marshall Wace, LLP | 0 | $0 | 0.00% | −581,471−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −415,938−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −293,664−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −228,817−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −148,021−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −126,798−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −90,698−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −79,476−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −74,229−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −48,127−100.0% | Sold out |
| EP Wealth Advisors, LLC | 0 | $0 | 0.00% | −41,167−100.0% | Sold out |
| Piper Sandler & Co. | 0 | $0 | 0.00% | −39,467−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −33,300−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −29,588−100.0% | Sold out |
| Diametric Capital, LP | 0 | $0 | 0.00% | −18,434−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −16,087−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −12,134−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −11,533−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −8,010−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |